Zobrazeno 1 - 10
of 27
pro vyhledávání: '"E, Blümner"'
Publikováno v:
Clinical and experimental rheumatology. 33(6)
Identification of B cell biomarkers predictive of response prior to therapy with rituximab (RTX) and evaluation of the efficacy of long-term treatment in patients with rheumatoid arthritis (RA).302 RA patients failing one TNFi were treated with two a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::808f75760ce4d86128268054201bd268
https://pubmed.ncbi.nlm.nih.gov/26517829
https://pubmed.ncbi.nlm.nih.gov/26517829
Autor:
D. Welzel, E. Blümner, W. Danielczyk, K. Überla, M. Gerlach, Horst Przuntek, Peter H. Kraus, H. J. Kaiser, H. Letzel, P. Riederer
Publikováno v:
Journal of Neural Transmission. 103:699-715
Long-term levodopa treatment in Parkinson's disease is typically associated with "motor side effects" consisting in dyskinesias and/or fluctuations in motility referred to as the on-off phenomena. The main objective of this prospective, randomized, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e037688f3903ec763b4fab636d2445c
https://doi.org/10.1007/bf01271230
https://doi.org/10.1007/bf01271230
Autor:
R. Waldmann, D.K. Hossfeld, B. Steinke, H. Caffier, E. Blümner, K. Possinger, S. Kunz, E. Neeser, E. Heidemann, J. Clark, J. Hartlapp, R. Souchon, G. V. Ingersleben, K. Schumacher
Publikováno v:
Oncology Research and Treatment. 16:344-353
Background: Since prolongation of survival by chemotherapy has been questioned, palliation balanced with an acceptable quality of life is the primary aim in treating patients with metastatic breast cancer. Patients and Methods: 224 patients from 11 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46376b589b3f2fe41ec12144efd74ecb
https://doi.org/10.1159/000218287
https://doi.org/10.1159/000218287
Autor:
E. Blümner, W. Danielczyk, K. Überla, P. H. Kraus, D. Schwarzmann, Horst Przuntek, H. Wolf, P. Riederer, D. Welzel, H. Letzel, H. J. Kaiser
Publikováno v:
European Journal of Clinical Pharmacology. 43:357-363
L-Dopa supplemented by a peripheral decarboxylase inhibitor is considered the most potent therapeutic regimen prolonging active life in Parkinsonian patients. The long-term benefit of therapy is limited by adverse effects, such as dyskinesia and on-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8d32c56c38568ca82b4055f58ffcef
https://doi.org/10.1007/bf02220609
https://doi.org/10.1007/bf02220609
Autor:
L. Gnuegge, H-P Tony, E. Blümner, Thomas Dörner, J. Kandenwein, Henrik E. Mei, A. Hammes, Petra Roll
Publikováno v:
Annals of the Rheumatic Diseases. 71:500.2-500
Background ReFIRST is an exploratory, multi-center, open label, uncontrolled phase IIIb study evaluating the efficacy of re-treatment with Rituximab (RTX). It is the extension of the FIRST study that included 302 RA patients. In a substudy, it was in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d9dba5824ce46695604974158a15ab7
https://doi.org/10.1136/annrheumdis-2012-eular.3037
https://doi.org/10.1136/annrheumdis-2012-eular.3037
Publikováno v:
Environmental Technology Letters. 9:491-500
Meta‐analyses of studies on lung cancer and passive smoking both by WALD and the authors have shown greater differences in the pooled relative risk. In our paper three scenarios with conservative rates of misclassification are assumed and their eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10ea5f97b9e983245cda90baef5016e
https://doi.org/10.1080/09593338809384596
https://doi.org/10.1080/09593338809384596
Publikováno v:
Arzneimittel-Forschung. 37(9)
Sotalol (Sotalex; Sotacor) is a beta-blocker with additional class III antiarrhythmic activity. In this study two intravenous doses of 1.5 mg/kg and 2 mg/kg body weight were administered in 8 healthy volunteers in order to determine the pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f82764f164a815f167183662d5d2000d
https://pubmed.ncbi.nlm.nih.gov/3435602
https://pubmed.ncbi.nlm.nih.gov/3435602
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.